Accepted at 8:39 p.m. Oct, 31, 2023 by Alex
Author: al099
Related Note: 1509302652566
Rationale for change

first aid 2022 says gastric cancer

Text Text
Extra
Growth factor receptor, thus has intrinsic tyrosine kinase activity
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy


Watch Monoclonal Antibody Therapy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Transplant Rejection : Biologic Immunotherapy

Watch associated Bootcamp video - Cellular Injury and Neoplasia : Cell Cycle Independent Drug Targets

Watch associated Bootcamp video - Esophageal and Gastric Pathology : Malignant Gastric Pathology

Watch associated Bootcamp video - Principles of Oncology and Therapeutics : Cell Cycle Independent Drug Targets
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::08_Biologic_Immunotherapy #AK_Step1_v12::#UWorld::COMLEX::25202 #AK_Step1_v12::#Bootcamp::Gastroenterology::05_Esophageal_and_Gastric_Pathology::07_Malignant_Gastric_Pathology #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::26_Trastuzumab #AK_Step1_v12::#AMBOSS::R4alQk #AK_Step1_v12::#OME_banner !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#UWorld::COMLEX::25557 #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Trastuzumab #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Monoclonal_Antibody_Therapy #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#UWorld::Step::11585 #AK_Step1_v12::^Systems::HemeOnc::RBC::MiscAdds #AK_Step1_v12::#UWorld::Step::2093 #AK_Step1_v12::#AMBOSS::k4amjk